Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Mar 9, 2022
Date Accepted: Aug 3, 2022
Positive Peers mobile application use improves clinical outcomes for young people with HIV: A prospective observational cohort comparison
ABSTRACT
Background:
The Positive Peers mobile application (PPA) is a multi-function HIV support tool designed to improve HIV related clinical outcomes for young people with HIV (YPWH). This pilot study included testing the effectiveness of the app among a single clinic patient population.
Objective:
This study assessed the effects of PPA use on HIV clinical outcomes.
Methods:
PPA users were compared to study eligible non-users receiving care at the same clinic during the study period (n = 259). All study participants were between the ages of 13 and 34, diagnosed with HIV, and either returning to care after an absence, or diagnosed within 12 months prior to study enrollment. Participant demographics and HIV care variables were extracted from the electronic health record (EHR). The PPA user group (n = 114) consented to download the app which provided natively tracked application usage data.
Results:
Analysis showed that younger PPA users (13-24) were more likely to achieve sustained viral suppression than non-users (AOR 4.2, 1.2-13.9).
Conclusions:
The Positive Peers mobile application appears to help younger users sustain HIV suppression. The freely available Positive Peers mobile application could be a helpful tool for achieving Ending the HIV Epidemic (EHE) goals. Clinical Trial: N/A
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.